These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 35318720)

  • 1. Incidence of allopurinol-induced severe cutaneous adverse drug reaction in Malaysia.
    Ng WL; Lim KS; Hariraj V; Lee SC; Wo WK; Ramli A; Lai PSM; Fong SL; Lim JR
    Br J Clin Pharmacol; 2022 Aug; 88(8):3782-3788. PubMed ID: 35318720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe cutaneous adverse reactions: A 5-year retrospective study at Hospital Melaka, Malaysia, from December 2014 to February 2020.
    Tee CT; Abdullah NH; Kristummoonthy P; Lee CS
    Med J Malaysia; 2022 Jul; 77(4):409-414. PubMed ID: 35902928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of Antiseizure Medication-Induced Severe Cutaneous Adverse Reactions in Malaysia.
    Fong SL; Lim KS; Hariraj V; Lee SC; Wo WK; Ramli A; Ho JH; Lai PSM; Ng WL
    J Clin Pharmacol; 2022 Aug; 62(8):983-991. PubMed ID: 35230712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced liver injury associated with severe cutaneous adverse drug reactions: A nationwide study in Taiwan.
    Huang YS; Wu CY; Chang TT; Peng CY; Lo GH; Hsu CW; Hu CT; Huang YH
    Liver Int; 2021 Nov; 41(11):2671-2680. PubMed ID: 34153177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allopurinol-Induced Severe Cutaneous Adverse Drug Reactions: An Analysis of Spontaneous Reports in Malaysia (2000-2018).
    Lee SC; Wo WK; Yeoh HS; Mohamed Ali N; Hariraj V
    Ther Innov Regul Sci; 2021 May; 55(3):514-522. PubMed ID: 33393015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation of ITGB2 contributes to allopurinol hypersensitivity.
    Liu Y; Wang CW; Chen CB; Yu KH; Wu YJ; Choon SE; Chang WC; Yang F; Luo XQ; Chung WH; Zhao M; Lu QJ
    Clin Immunol; 2023 Mar; 248():109250. PubMed ID: 36738816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Individual Case Safety Reports of Severe Cutaneous Adverse Reactions in Korea.
    Kang MG; Sohn KH; Kang DY; Park HK; Yang MS; Lee JY; Kang HR
    Yonsei Med J; 2019 Feb; 60(2):208-215. PubMed ID: 30666843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining the use of allopurinol: Perspectives from recent drug injury relief applications.
    Huang CH; Chu MP; Chen WW
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 2):371-377. PubMed ID: 29941331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbamazepine-Induced Severe Cutaneous Adverse Drug Reactions: A 21-Year Comparison Between Children and Adults in Malaysia.
    Hariraj V; Wo WK; Lee SC; Ramli A
    J Clin Pharmacol; 2023 Oct; 63(10):1126-1132. PubMed ID: 37291071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Stevens-Johnson syndrome following combination drug use of allopurinol, carbamazepine and phenytoin in Taiwan: A case-control study.
    Syu FK; Pan HY; Chuang PC; Huang YS; Cheng CY; Cheng FJ
    J Dermatol; 2018 Sep; 45(9):1080-1087. PubMed ID: 29963717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
    Choon SE; Lai NM
    Indian J Dermatol Venereol Leprol; 2012; 78(6):734-9. PubMed ID: 23075643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of HLA-B*58: 01 genetic testing before initiation of allopurinol therapy to prevent allopurinol-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in a Malaysian population.
    Chong HY; Lim YH; Prawjaeng J; Tassaneeyakul W; Mohamed Z; Chaiyakunapruk N
    Pharmacogenet Genomics; 2018 Feb; 28(2):56-67. PubMed ID: 29176400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions.
    Chung WH; Pan RY; Chu MT; Chin SW; Huang YL; Wang WC; Chang JY; Hung SI
    J Invest Dermatol; 2015 Sep; 135(9):2237-2248. PubMed ID: 25946710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.
    Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W
    Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanisms of Severe Cutaneous Adverse Reactions and a New Treatment Strategy].
    Saito Y; Nakamura R
    Yakugaku Zasshi; 2019; 139(12):1557-1562. PubMed ID: 31787645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allopurinol-induced severe cutaneous adverse drug reactions: Risk minimization measures in Malaysia.
    Panickar R; Wo WK; Ali NM; Tang MM; Ramanathan GRL; Kamarulzaman A; Aziz Z
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1254-1262. PubMed ID: 33084196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical profiles of Stevens-Johnson syndrome among Thai patients.
    Limpawattana P; Choonhakarn C; Kongbunkiat K
    J Dermatol; 2014 Jul; 41(7):634-7. PubMed ID: 24815085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the HLA-B(*)58:01 Allele and Renal Impairment on Allopurinol-Induced Cutaneous Adverse Reactions.
    Ng CY; Yeh YT; Wang CW; Hung SI; Yang CH; Chang YC; Chang WC; Lin YJ; Chang CJ; Su SC; Fan WL; Chen DY; Wu YJ; Tian YC; Hui RC; Chung WH;
    J Invest Dermatol; 2016 Jul; 136(7):1373-1381. PubMed ID: 26996548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allopurinol-Induced Stevens-Johnson Syndrome.
    Gupta SS; Sabharwal N; Patti R; Kupfer Y
    Am J Med Sci; 2019 Apr; 357(4):348-351. PubMed ID: 30638600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of Stevens-Johnson syndrome/toxic epidermal necrolysis among new users of different individual drugs in a European population: a case-population study.
    Rodríguez-Martín S; Martín-Merino E; Lerma V; Rodríguez-Miguel A; González O; González-Herrada C; Ramírez E; Bellón T; de Abajo FJ
    Eur J Clin Pharmacol; 2019 Feb; 75(2):237-246. PubMed ID: 30298362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.